Letter to the Editor
Leukemia (2006) 20, 2057–2060. doi:10.1038/sj.leu.2404400; published online 28 September 2006
A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib
F X Gruber1, H Hjorth-Hansen2, I Mikkola1, L Stenke3 and T Johansen4
- 1Department of Pharmacology, Institute of Pharmacy, University of Tromsø, Tromsø, Norway
- 2Department of Hematology, St Olavs Hospital, Trondheim, Norway
- 3Hematology Centre, Karolinska University Hospital and Institute, Stockholm, Sweden
- 4Department of Biochemistry, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
E-mail: franz.gruber@farmasi.uit.no
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
Bone Marrow Transplantation Review
Nature Reviews Cancer Review (01 May 2007)
RESEARCH
Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR
Leukemia Letter
Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia
Leukemia Original Article
Leukemia Letter
